These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of thrombin in angiogenesis and tumor progression. Tsopanoglou NE; Maragoudakis ME Semin Thromb Hemost; 2004 Feb; 30(1):63-9. PubMed ID: 15034798 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor. Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248 [TBL] [Abstract][Full Text] [Related]
4. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971 [TBL] [Abstract][Full Text] [Related]
5. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis. Scarpino S; D'Alena FC; Di Napoli A; Ballarini F; Prat M; Ruco LP J Pathol; 2003 Feb; 199(2):243-50. PubMed ID: 12533838 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules. Zachary I IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611 [TBL] [Abstract][Full Text] [Related]
7. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733 [TBL] [Abstract][Full Text] [Related]
8. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
9. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. Kim MH J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886 [TBL] [Abstract][Full Text] [Related]
10. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990 [TBL] [Abstract][Full Text] [Related]
11. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1). Chen WS; Kitson RP; Goldfarb RH In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150 [TBL] [Abstract][Full Text] [Related]
15. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933 [TBL] [Abstract][Full Text] [Related]
16. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086 [TBL] [Abstract][Full Text] [Related]
17. Coagulation proteases and human cancer. Sampson MT; Kakkar AK Biochem Soc Trans; 2002 Apr; 30(2):201-7. PubMed ID: 12023851 [TBL] [Abstract][Full Text] [Related]
18. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. Guo Y; Wang S; Hoot DR; Clinton SK J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033 [TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. Jiang C; Agarwal R; Lü J Biochem Biophys Res Commun; 2000 Sep; 276(1):371-8. PubMed ID: 11006131 [TBL] [Abstract][Full Text] [Related]